Skip to main content
Ophthalmology and Therapy logoLink to Ophthalmology and Therapy
. 2022 Jan 31;11(2):923. doi: 10.1007/s40123-022-00467-1

Correction to: Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States

Kimberly P Cockerham 1,2, Lissa Padnick-Silver 3, Noel Stuertz 3, Megan Francis-Sedlak 3, Robert J Holt 3,
PMCID: PMC8927549  PMID: 35102515

Correction to: Ophthalmol Ther (2021) 10:975–987 10.1007/s40123-021-00385-8

The original publication contained an error regarding the appearance-related and vision-related QOL scores. The data as it appears in the abstract (results section) is correct: “The overall GO-QOL score was 60.5 ± 21.8 (vision-related: 58.6 ± 24.0, appearance-related: 62.3 ± 25.1).” However, this data was incorrectly published under the results section in the main text. The first sentence under the subheading “Effect of Thyroid Eye Disease on Quality of Life and Mental Health” should read: “Patient QOL was markedly impaired by TED at the time of survey, as indicated by an overall GO-QOL score of 60.5 ± 21.8, an appearance sub-score of 62.3 ± 25.1, and a visual function sub-score of 58.6 ± 24.0.”

The original article has been corrected.

Contributor Information

Kimberly P. Cockerham, Email: cockerhammd@gmail.com

Lissa Padnick-Silver, Email: lsilver@horizontherapeutics.com.

Noel Stuertz, Email: nstuertz@horizontherapeutics.com.

Megan Francis-Sedlak, Email: mfrancis-sedlak@horizontherapeutics.com.

Robert J. Holt, Email: rholt@horizontherapeutics.com


Articles from Ophthalmology and Therapy are provided here courtesy of Springer

RESOURCES